Purpose and Importance

Before any new drug or formulation can be tested in humans, it must undergo rigorous toxicological and preclinical studies to assess its safety profile. These studies form the foundation of every successful Investigational New Drug (IND) application and are mandatory under international guidelines such as OECD, ICH, USFDA, and EMA.

Preclinical testing evaluates how a drug interacts with biological systems, helping identify potential toxic effects before human exposure. It ensures that only safe candidates progress to clinical trials, reducing the risk of adverse effects.

Toxicological studies assess parameters such as organ toxicity, reproductive safety, genotoxicity, and carcinogenic potential. These results determine safe dosage levels, exposure limits, and overall risk assessment for regulatory approval.

Our Testing Capabilities

Accuprec Research Labs offers a full range of GLP-compliant toxicology and safety pharmacology studies using state-of-the-art facilities and validated protocols. Our key study areas include:

• Acute and Sub-Chronic Toxicity Studies: Identify dose-related effects over short and medium durations.
• Chronic Toxicity Studies: Long-term exposure assessments to detect delayed or cumulative effects.
• Reproductive and Developmental Toxicity Studies: Evaluate impacts on fertility, embryonic development, and offspring health.
• Genotoxicity and Mutagenicity Testing: Detect DNA damage or genetic mutations caused by drugs or metabolites.
• Carcinogenicity Studies: Assess long-term potential to induce cancerous changes.
• Safety Pharmacology: Evaluate effects on vital organ systems such as cardiovascular, respiratory, and nervous systems.

Our Approach

Our testing follows a scientific and ethical framework emphasizing animal welfare and data integrity. All studies are conducted in GLP-certified animal facilities under the supervision of experienced veterinarians and toxicologists. We ensure compliance with global regulatory standards and provide detailed study reports formatted for submission to authorities like the FDA, EMA, and CDSCO.

Why Choose Accuprec

• OECD-GLP and AAALAC Certified Facilities: Ensuring data credibility and compliance.
• Experienced Team: 200+ scientists specializing in regulatory toxicology.
• Integrated Services: From study design to final report submission.
• Regulatory-Ready Documentation: Supporting IND/NDA submissions worldwide.

Outcome

Accuprec’s toxicological and preclinical testing services provide a strong scientific foundation for safe drug development. With our proven expertise, global compliance, and reliable data, we help pharmaceutical companies advance their innovations from laboratory to clinical trials with confidence.